文献速递多重用药老年综合评估

评估老年人对合理多重用药的依从性:干预试验结局指标的选择

Assessing Older Adults' Adherence to Appropriate Polypharmacy: Selection of Outcome Measures for Intervention Trials.
PubMed 文献 · J Am Geriatr Soc · 2026-01-29

本研究旨在为关注老年人合理多重用药依从性的核心结局集(COS)选择结局测量工具(OMIs)。通过文献整理、两轮德尔菲问卷(第一轮42人、第二轮39人)及共识会议(专家5人、公众1人),最终选定四种OMIs分别测量多药依从性(主观)、治疗负担、健康相关生活质量和不良事件及副作用,成本效果和医疗利用未达成共识。

要点

  • 选定ARMS(100%)测量多药依从性(主观)。
  • 选定MTBQ(100%)测量治疗负担。
  • 选定MRB-QoL(83.3%)测量健康相关生活质量。

核心结论

  • 本研究为改善老年人合理多重用药依从性的研究选定四种OMIs用于COS,成本效果和医疗利用的OMIs尚待未来研究确定。

研究设计与样本

  • 通过文献整理OMIs列表,进行两轮德尔菲问卷(第一轮42人、第二轮39人)和共识会议(专家5人、公众1人),以≥80%参与者评为关键且≤20%评为不重要为纳入标准。

主要发现

  • 共识会议后选定四种OMIs:ARMS(100%)、MTBQ(100%)、MRB-QoL(83.3%)和「干预导致的多药不良后果数量」(83.3%)。
  • 成本效果和医疗利用未达成共识。

关键数值与推荐

  • OMI纳入标准:≥80%参与者投票为关键且≤20%投票为不重要。
  • ARMS用于测量多药依从性(主观),得票100%。
  • MTBQ用于测量治疗负担,得票100%。
  • MRB-QoL用于测量健康相关生活质量,得票83.3%。
  • 「干预导致的多药不良后果数量」用于测量不良事件及副作用,得票83.3%。

临床怎么用

  • 在评估老年人合理多重用药依从性的干预试验中,可考虑使用ARMS、MTBQ、MRB-QoL及多药不良后果数量作为结局测量工具。

局限性

  • 成本效果和医疗利用的OMIs未达成共识,需未来研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcome measurement instruments (OMIs) are important for evaluating intervention effectiveness and quality. However, adopting OMIs remains challenging. This study aimed to select OMIs for a core outcome set (COS) for use in studies focusing on adherence to appropriate polypharmacy in older people. METHODS: A list of OMIs for COS outcomes and their feasibility information was compiled from the literature to select one OMI per outcome. Two rounds of Delphi questionnaires containing a range of OMIs were distributed to experts [academics, healthcare professionals (HCPs), journal editors and methodologists] who were asked to select OMIs for a subsequent consensus meeting using 'Yes', 'No', or 'Uncertain'. The Delphi results were discussed and OMIs were voted on (Yes: important and No: unimportant) in a consensus meeting with experts and an interview with a public member. An OMI was included if ≥ 80% of participants voted on it as critical and ≤ 20% voted it as unimportant. RESULTS: Twenty-one OMIs were presented to experts (Round 1, n = 42; Round 2, n = 39) in the Delphi exercise to achieve consensus on nine OMIs. Following the consensus meeting and interview (experts, n = 5; public participants, n = 1), agreement was achieved to select four OMIs: the Adherence to Refills and Medications Scale (ARMS, 100%); Multimorbidity Treatment Burden Questionnaire (MTBQ, 100%); Medication-Related Burden Quality of Life questionnaire (MRB-QoL, 83.3%); and 'the number of undesired consequences of the intervention that result from administering multiple medications in older people (83.3%)' for measuring medication adherence across multiple medications (subjective); treatment burden; health-related quality of life (HRQoL) and adverse events and side effects (AEs and SEs), respectively. No agreement was reached regarding cost-effectiveness and healthcare utilization. CONCLUSION: This study selected OMIs for use with a COS in studies to improve adherence to appropriate polypharmacy in older people. Future research should identify appropriate OMIs for the remaining outcomes.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Al Shaker HA, Barry HE, Hughes CM, et al. Assessing Older Adults' Adherence to Appropriate Polypharmacy: Selection of Outcome Measures for Intervention Trials. J Am Geriatr Soc. 2026. PMID: 41609220. doi:10.1111/jgs.70313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。